pentobarbital will decrease the extent or outcome of guanfacine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Carefully. Sturdy or reasonable CYP3A4 inducers noticeably reduce guanfacine plasma concentrations and elimination half-everyday living.pentobarbital will lessen the level or influence of repaglinide